Home›Stock Screener›Syngene International

Syngene International Share Price Today | Stock Price & Syngene International Share Screener

SYNGENE Healthcare Services
Live Share Price NSE
₹434.80
▲ 0.45 (0.10%)
2026-11-18 00:00:00
Live Share Price BSE
₹435.05
▲ 1.00 (0.23%)
2026-11-18 00:00:00

As of November 18, 2026, the live Syngene International share price (NSE: SYNGENE) is ₹434.80 on NSE and ₹435.05 on BSE, up 0.10% from the previous close, with shares trading between ₹430.80 and ₹445.95 in today's trading session, and a 52-week range of ₹346.00–₹660.35. Track Syngene International market cap to gauge the company's total market size. Use the Syngene International stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Syngene International opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹861 and net income of ₹32, with EBITDA of ₹169, an operating margin of 17.0% and a profit margin of 3.7%.

Syngene International Market Cap ₹17,575.75 Cr.
SYNGENE P/E Ratio (TTM) 95.70
Syngene International P/B Ratio 3.67
EPS (TTM) ₹7.87
Dividend Yield 0.28%
Debt to Equity 0.11
SYNGENE 52 Week High ₹660.35
Syngene International 52 Week Low ₹346.00
Operating Margin 17.00%
Profit Margin 3.72%
SYNGENE Revenue (TTM) ₹861.00
EBITDA ₹169.00
Net Income ₹32.00
Total Assets ₹7,055.00
Total Equity ₹4,839.00

Syngene International Share Price Chart

Track the current stock price of Syngene International with an interactive chart. Analyse SYNGENE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Syngene International stock quote in one place.

The quote of ₹434.80 sits between the 52-week low of ₹346.00 and the 52-week high of ₹660.35, and the latest session moved 0.10% from the previous close.

Syngene International Company Profile - Fundamental Screener

Screen Syngene International company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SYNGENE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, with Kiran Mazumdar Shaw listed as chairperson or CEO, and it trades under ISIN INE398R01022.

Business Overview

Syngene International Limited is an integrated research, development, and manufacturing services company headquartered in India. It serves global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The company operates across four business divisions: Discovery Services, Development Services, Manufacturing Services, and Dedicated Centers. With approximately 6000 scientists, Syngene...more

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

Chairperson/CEO Kiran Mazumdar Shaw
ISIN INE398R01022

Syngene International Balance Sheet Screener

Screen SYNGENE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹7,055, up from ₹6,796 in 2025.

Latest statistics put total assets at ₹7,055 and shareholder funds at ₹4,839, with a leverage ratio of 0.11.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018

Assets

Total Assets 7,055 6,796 6,152 5,831 5,564 4,883 4,163 3,704 3,189
Current Assets 0 0 0 0 0 0 0 0 0
Fixed Assets 3,000 2,802 2,850 2,667 2,393 2,201 2,020 1,377 1,030

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0
Current Liabilities 663 673 750 1,025 1,037 929 448 607 685
Non-Current Liabilities 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 4,839 4,727 4,258 3,618 3,298 2,821 2,176 1,968 1,720
Share Capital 403 403 402 401 401 400 400 200 200
Reserves & Surplus 4,436 4,324 3,856 3,217 2,897 2,421 1,776 1,768 1,520

Syngene International Income Statement Screener - Profit & Revenue Analysis

Screen Syngene International income statement and profit fundamentals. Analyze SYNGENE quarterly results. Syngene International reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹861 and net profit was ₹32, equal to earnings per unit of ₹0.80, at an operating margin of 17%.

In that period expenses were ₹692, interest cost ₹10 and tax ₹15. The next period listed, 2026-Jun, shows revenue of ₹761 and net profit of ₹-9.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar

Revenue and Expenses

Revenue 861 761 1,059 933 926 892 1,037 962 908 840 933 883 932 832 1,017
Expenses 692 659 739 779 711 668 674 660 646 620 600 626 663 596 680

Operating Costs and Margins

EBITDA 169 103 320 154 215 224 363 302 261 220 333 257 268 236 337
Operating Profit % 17.00% 11.00% 29.00% 15.00% 22.00% 24.00% 34.00% 30.00% 27.00% 22.00% 35.00% 27.00% 27.00% 26.00% 32.00%
Depreciation 112 112 112 114 117 111 106 109 111 107 111 108 105 102 96
Interest 10 10 12 12 13 12 16 12 13 12 13 11 13 11 10

Profit and Earnings

Profit Before Tax 47 -19 196 28 85 101 241 181 137 101 209 138 151 123 231
Tax 15 -10 48 13 18 15 57 50 31 26 20 27 34 30 52
Net Profit 32 -9 148 15 67 87 183 131 106 76 189 112 117 93 179
EPS 0.80 -0.22 3.68 0.37 1.67 2.16 4.56 3.27 2.64 1.89 4.70 2.78 2.90 2.33 4.36

Syngene International Cash Flow Screener - Liquidity Fundamentals

Screen SYNGENE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹915, and net cash flow was an outflow of ₹139.

Over the same period, investing activities used ₹839 and financing activities used ₹215.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March

Cash from Operations and Investing

Operating Activities 915 1,168 1,042 824 581 701 677 630 446
Investing Activities -839 -744 -495 -653 -611 -629 -424 -646 -349

Financing and Net Cash

Financing Activities -215 -142 -551 -343 -31 58 -226 -72 -79
Net Cash Flow -139 281 -4 -172 -62 130 28 -88 18

Syngene International Shareholding Pattern Screener

See Syngene International shareholding pattern with promoter, FII, and DII holdings. Check Syngene International promoter holding and ownership changes for SYNGENE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 52.59%, foreign institutions 10.14%, domestic institutions 29.30% and the public 6.27%, spread across 134,008 shareholders.

The shareholder count was 134,008 in 2026-Sept, compared with 142,277 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 52.59% 52.59% 52.68% 52.68% 52.68% 52.68% 52.74% 52.74%

Institutional Investors

FII Holding 10.14% 11.82% 13.90% 14.96% 16.31% 16.50% 19.47% 20.64%
DII Holding 29.30% 28.02% 26.44% 25.84% 24.62% 24.05% 21.50% 19.53%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 6.27% 6.14% 5.51% 5.37% 5.28% 5.59% 5.08% 5.59%
Other Holding 1.70% 1.44% 1.46% 1.15% 1.10% 1.18% 1.21% 1.50%
Shareholder Count 134,008 142,277 135,605 131,750 136,061 142,310 125,090 128,806

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Syngene International. Syngene International dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹1.25 per unit for 2026-March, a yield of 0.28%, compared with ₹1.25 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹1.25, ₹1.25 and ₹1.25 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹1.25 0.28%
2025-March ₹1.25 0.32%
2024-March ₹1.25 0.17%
2023-March ₹1.25 0.18%
2022-March ₹1.00 0.17%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.50 0.21%
2018-March ₹1.00 0.34%
2017-March ₹1.00 0.33%

Syngene International Stock Index Membership - Nifty & Sensex

See which indices include Syngene International stock. Check SYNGENE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 22 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX LMI250.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX LMI250
BSE INDEX MID150
BSE INDEX MSL400
BSE INDEX SMLCAP
BSE INDEX SMLSEL
NIFTY 500
NIFTY HEALTHCARE
NIFTY LARGEMID250
NIFTY M150 QLTY50
NIFTY MIDCAP 150
NIFTY MIDSMALLCAP400 MOMENTUM QUALITY 100
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH
NIFTYM150MOMNTM50

Syngene International Market Events Screener - Corporate Actions

Get Syngene International corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Syngene International stock events that may affect SYNGENE share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 27, 2026, with a record date of October 27, 2026.

It is followed by Quarterly Result Announcement dated July 29, 2026 and Annual General Meeting dated July 29, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-27 2026-10-27 Quarterly Result Announcement NA -0.12%
2026-07-29 2026-07-29 Quarterly Result Announcement NA -3.18%
2026-07-29 2026-07-29 Annual General Meeting NA -6.99%
2026-06-25 2026-06-26 Dividend ₹ 1.25 /share -0.89%
2026-04-29 2026-04-29 Quarterly Result Announcement NA 9.19%
2026-01-22 2026-01-22 Quarterly Result Announcement NA -8.51%
2025-11-05 2025-11-05 Quarterly Result Announcement NA 2.52%
2025-07-23 2025-07-23 Quarterly Result Announcement NA 6.63%
2025-07-23 2025-07-23 Annual General Meeting NA -8.05%
2025-06-27 2025-06-27 Dividend ₹ 1.25 /share -12.18%
2025-04-23 2025-04-23 Quarterly Result Announcement NA 5.45%
2025-01-23 2025-01-23 Quarterly Result Announcement NA -3.68%
2024-10-23 2024-10-23 Quarterly Result Announcement NA -5.14%
2024-07-24 2024-07-24 Annual General Meeting NA 8.09%
2024-06-28 2024-06-28 Dividend ₹ 1.25 /share 1.73%

Syngene International Competitors Screener - Peer Stocks Comparison

Screen SYNGENE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 126,329 53.90 25,420 15.58% 2,003 64.36
Max Healthcare Institute 100,095 71.20 8,536 18.82% 1,442 73.63
Manipal Health Enterprises 93,622 104.20 10,521 25.80% 917 58.01
Aster DM Quality Care 64,857 116.10 4,769 11.25% 427 61.53
Fortis Healthcare 60,876 57.00 9,179 16.93% 1,064 56.49
Narayana Hrudayalaya 38,906 45.00 7,996 43.43% 811 60.17
Global Health 38,884 62.80 4,509 19.56% 554 63.26
Dr. Lal Path Labs 33,632 57.20 2,864 12.11% 510 57.81
Syngene International 17,576 95.70 3,809 2.56% 317 66.04
Krishna Institute of Medical Sciences 32,040 163.00 3,931 28.16% 242 65.46

Syngene International Company Announcements - News & Reports Screener

Screen SYNGENE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated November 16, 2026 and November 2, 2026.

Date Update Actions
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-11-16 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-11-02 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-10-29 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-28 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-10-27 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-10-27 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-27 Announcement under Regulation 30 (LODR)-Change in Management -
2026-10-27 Results- Financial Results For September 30 2026. -
2026-10-27 Board Meeting Outcome for Outcome Of Board Meeting -
2026-10-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-08 Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ending September 30 2026. -
2026-09-25 Closure of Trading Window -
2026-09-24 Intimation Of Cancellation Of Meeting With Analyst/Institutional Investors -
2026-09-21 Announcement under Regulation 30 (LODR)-Change in Management -
2026-09-21 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-11 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-10 Communication Regarding Remittance Of Final Dividend For The FY 2025-26 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹434.80, within a 52-week range of ₹346.00 to ₹660.35. The P/E ratio is 95.70 and the P/B ratio is 3.67, with earnings per unit of ₹7.87. Market capitalisation stands at ₹17,575.75 Cr and the dividend yield is 0.28%. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 9 balance sheet periods, 15 income statement periods, 9 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.